Venetoclax in Combination With Decitabine and Cedazuridine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
ACTIVE_NOT_RECRUITING
Status
Conditions
- Recurrent Acute Biphenotypic Leukemia
- Recurrent Acute Myeloid Leukemia
- Refractory Acute Biphenotypic Leukemia
- Refractory Acute Myeloid Leukemia
Interventions
- DRUG: Decitabine and Cedazuridine
- DRUG: Venetoclax
Sponsor
M.D. Anderson Cancer Center